The sale is a routine 10b5-1 plan execution by an officer, with consistent monthly volume (~16,666 shares). No unusual insider behavior detected. Monitor for any acceleration of sales or changes in the plan.
Price Chart
Executive Summary
Beth Hecht, an officer of Xeris Biopharma Holdings, Inc., filed a Form 144 on October 1, 2026, indicating intent to sell 16,666 shares of common stock, with an estimated aggregate market value of approximately $159,327. The proposed sale is part of a 10b5-1 trading plan, with prior sales under the same plan in August and September 2026.
Key Facts
- Filer: Beth Hecht, an officer of Xeris Biopharma Holdings, Inc.
- Proposed sale: 16,666 shares of common stock.
- Estimated aggregate market value: $159,326.96.
- Shares acquired via restricted stock units (15,229 shares) and open market purchase (1,437 shares).
- Sale is part of a 10b5-1 trading plan, with prior sales on 08/03/2026 and 09/01/2026 under the same plan.
- Filing date: October 1, 2026.
Financial Impact
Proposed sale of 16,666 shares valued at ~$159,327, representing a small fraction of the company's market cap.
Risk Factors
- Insider selling may signal lack of confidence if volume increases significantly.
- 10b5-1 plan provides a defense against insider trading allegations but does not eliminate signaling risk.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-009959 |
| Document: 0001950047-26-009959-index.html | 0001950047-26-009959 |
| Document: 0001950047-26-009959.txt | 0001950047-26-009959 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 15d ago | 8-K | $9.77 | awaiting T+20 | awaiting T+20 | $10.75 (+10.03%) |
Oct 2, 2026 27d ago | Insider Cluster | $10.13 | awaiting T+20 | awaiting T+20 | $10.75 (+6.12%) |
Oct 1, 2026 28d ago | 144 | $9.08 | awaiting T+20 | awaiting T+20 | $10.75 (+18.39%) |
Sep 9, 2026 7w ago | 8-K | $7.71 $10.11 | ▲ +31.13% | ▲ +29.18% | $10.75 (+39.43%) |
Sep 1, 2026 8w ago | Insider Cluster | $8.58 $9.56 | ▲ +11.42% | ▲ +11.51% | $10.75 (+25.29%) |
Aug 6, 2026 12w ago | 8-K | $7.36 $8.59 | ▲ +16.71% | ▲ +16.11% | $10.75 (+46.06%) |
Aug 4, 2026 12w ago | Insider Cluster | $8.11 $8.58 | ▲ +5.80% | ▲ +6.40% | $10.75 (+32.55%) |
Jul 7, 2026 16w ago | Insider Cluster | $8.67 $8.11 | ▲ +6.46% | ▲ +9.73% | $10.75 (−23.99%) |
Jul 2, 2026 17w ago | 3 | $8.28 $8.42 | ▲ +1.69% | ▲ +2.11% | $10.75 (+29.83%) |
Jul 2, 2026 17w ago | Insider Cluster | $8.37 $8.13 | ▼ −2.87% | ▼ −3.72% | $10.75 (+28.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers